MICHAEL G. GREY - 31 Aug 2022 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Executive Chairman, Director
Signature
/s/ Michael P. Cruse, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
31 Aug 2022
Net transactions value
+$98,500
Form type
4
Filing time
02 Sep 2022, 17:10:09 UTC
Previous filing
06 Jun 2022
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Options Exercise $98,500 +50,000 $1.97 50,000 31 Aug 2022 Direct
holding RPHM Common Stock 134,084 31 Aug 2022 By Trust F1
holding RPHM Common Stock 444,762 31 Aug 2022 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock option (right to buy) Options Exercise $0 -50,000 -43% $0.000000 67,406 31 Aug 2022 Common Stock 50,000 $1.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By Michael George Grey and Rondi Rauch Grey, Co-Trustees of The Grey 2014 Irrevocable Children's Trust u/a/d 12/17/14
F2 By The Grey Family Trust dated November 12, 1999